Cargando…
Quantification of Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Tumor Specimen Shrinkage after Formalin Fixation
SIMPLE SUMMARY: As the evidence in apocrine gland anal sac adenocarcinoma tumors grows, it is becoming more evident that stage-specific treatment strategies will become the mainstay. Thus, having confidence in the measurements of primary tumors is paramount. We aimed to quantify the degree of tumor...
Autores principales: | Wustefeld-Janssens, Brandan G., Vinayak, Arathi, Parker, Lindsay A., Hollenbeck, Danielle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330584/ https://www.ncbi.nlm.nih.gov/pubmed/35892519 http://dx.doi.org/10.3390/ani12151869 |
Ejemplares similares
-
Apocrine gland anal sac adenocarcinoma with perineural metastasis in
a cat
por: Raleigh, Joseph S, et al.
Publicado: (2018) -
Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020) -
Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
por: Morello, Emanuela Maria, et al.
Publicado: (2021) -
Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma
por: Minoli, Lucia, et al.
Publicado: (2022) -
Evaluation of electrochemotherapy in the management of apocrine gland anal sac adenocarcinomas in dogs: A retrospective study
por: Valenti, Paola, et al.
Publicado: (2021)